KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Encompass Health (EHC) over the last 16 years, with FY2024 value amounting to -$653.3 million.

  • Encompass Health's Cash from Investing Activities fell 2464.4% to -$201.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$683.7 million, marking a year-over-year decrease of 1802.18%. This contributed to the annual value of -$653.3 million for FY2024, which is 837.76% down from last year.
  • Latest data reveals that Encompass Health reported Cash from Investing Activities of -$653.3 million as of FY2024, which was down 837.76% from -$602.8 million recorded in FY2023.
  • Encompass Health's Cash from Investing Activities' 5-year high stood at -$407.5 million during FY2020, with a 5-year trough of -$666.3 million in FY2021.
  • Over the past 5 years, Encompass Health's median Cash from Investing Activities value was -$627.0 million (recorded in 2022), while the average stood at -$591.4 million.
  • As far as peak fluctuations go, Encompass Health's Cash from Investing Activities soared by 3801.34% in 2020, and later tumbled by 6350.92% in 2021.
  • Encompass Health's Cash from Investing Activities (Annual) stood at -$407.5 million in 2020, then tumbled by 63.51% to -$666.3 million in 2021, then grew by 5.9% to -$627.0 million in 2022, then increased by 3.86% to -$602.8 million in 2023, then dropped by 8.38% to -$653.3 million in 2024.
  • Its Cash from Investing Activities stands at -$653.3 million for FY2024, versus -$602.8 million for FY2023 and -$627.0 million for FY2022.